21 May 2009
Obesity in patients after kidney transplantation
K Mucha, B Foroncewicz, M Ryter, J Ziółkowski, D Porowski, A Chmura, J Szmidt, L PączekAnn Transplant 2009; 14(1): 35-35 :: ID: 880324
Abstract
Background: Obesity is a well known risk factor of cardiovascular events and
was proven to affect both patient and graft survival of kidney transplant
recipients. The aim of the study was to analyze the incidence of obesity and the outcomes of obese renal transplant recipients. Additionally, the awareness of
their body mass index (BMI) and obesity-related risks were evaluated.
Material/Methods: In the randomly selected 60 renal transplant recipients we conducted a survey with 26 questions addressed. We analyzed patients with regard to: demographics, immunosuppression, incidence of obesity hypertension, co-incidence of diabetes mellitus (DM) and quality of life. The data obtained from the questionnaire was compared to the patient's medical history and lab results. BMI and serum creatinine concentrations were compared 3-months after transplantation (point-T) and at the moment of survey (point-S).
Results: The time elapsed between T and S-points ranged from 1-20 years
(46% <5 y.; 44% 5-10 y.; 8% 10-15 y. and 2% 15-20 y.). Percentage of obese
and overweighed patients increased after transplantation. At the point-T, obesity was found in 9%, overweight in 27% of recipients in comparison to 17% and 38% at point-S, respectively (p<0.05 for both comparisons). Serum creatinine between T and S-points, increased non-significantly in all patients regardless of BMI. Interestingly, DM type 2 was found in 9.6% of patients only with BMI=25-29.9. On the contrary, type 1 DM was observed in 3.9% of patients with BMI=19-24.9 and 5.7% with BMI=30-39.9. 98.2% of patients knew their body mass, however 61.8% of them cannot assess it with the use of BMI formula.
Conclusions: BMI over 25 was found to be associated with higher risk of DM. Unfortunately, majority of renal transplant recipients are not aware of their BMI. Therefore, authors proposed educational program dedicated to such population of patients.
Keywords: Kidney Transplantation, clinical outcome, Poland
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






